D.E. Shaw & Co
BCAB icon

D.E. Shaw & Co’s BioAtla BCAB Stock Holding History

D.E. Shaw & Co’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,312
Closed -$614K – 5184
2022
Q2 		$614K Sell
4,312
-1,725
-29% -$275K ﹤0.01% 3978
2022
Q1 		$1.51M Buy
6,037
+5,442
+915% +$2.28M ﹤0.01% 3571
2021
Q4 		$584K Buy
+595
New +$761K ﹤0.01% 4316

Other funds holding BCAB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

D.E. Shaw & Co's BCAB Position: Q3 2022 in Review

D.E. Shaw & Co sold out of BioAtla (BCAB) in Q3 2022, closing a stake of 4,312 shares — an estimated $614K sold.

D.E. Shaw & Co first reported a position in BCAB in Q4 2021 and held it in 3 quarters. The position peaked at $1.51M in Q1 2022. 73 funds tracked by Wall St. Rank hold BCAB as of Q3 2022.

  • D.E. Shaw & Co reported no remaining BioAtla position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 4,312 BioAtla shares in Q3 2022, an estimated $614K.
  • D.E. Shaw & Co first reported a position in BioAtla in Q4 2021 and held it in 3 quarters.
  • D.E. Shaw & Co's BioAtla position peaked at $1.51M in Q1 2022.
  • 73 funds tracked by Wall St. Rank held BioAtla as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.